Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.

Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q39197614
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaRASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.MicroRNA-148b enhances proliferation and apoptosis in human renal cancer cells via directly targeting MAP3K9.Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer CellsIn vivo genetic dissection of tumor growth and the Warburg effectEvaluate the Antigenotoxicity and Anticancer Role of β-Sitosterol by Determining Oxidative DNA Damage and the Expression of Phosphorylated Mitogen-activated Protein Kinases', C-fos, C-jun, and Endothelial Growth Factor Receptor.Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.Molecular and physiological roles of the adaptor protein CARD9 in immunity.Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner.MAPKs' status at early stages of renal carcinogenesis and tumors induced by ferric nitrilotriacetate.Genetic Alterations of TRAF Proteins in Human CancersHuman CARD9: A Critical Molecule of Fungal Immune SurveillanceHypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas
P2860

Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q39197614
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@en
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@nl
type
label
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@en
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@nl
prefLabel
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@en
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
@en
P2093
P304
P31
P356
10.1158/0008-5472.CAN-12-2362
P407
P433
P478
P577
P698